Genomic Sequencing

The importance of defining actionability as related to disclosure of secondary findings identified in research

When to disclose a borderline incidental finding

To disclose or not to disclose: Secondary findings of XXY chromosomes

Interview Guide: Genetic Health Professionals’ Experiences with Informed Consent in Diagnostic Genomic Sequencing

This interview guide seeks to understand genetic health professionals' experiences with obtaining informed consent for diagnostic genomic sequencing from patients.

Select ethical aspects of next-generation sequencing tests for newborn screening and diagnostic evaluation of critically ill newborns

Development and validation of a comprehensive genomics knowledge scale

Sequence three million genomes across Africa

Ambroise Wonkam

Genomic Sequencing

When "actionable" genomic sequencing results cannot be acted upon

Respecting autonomy and balancing benefits by disclosing the secondary finding of Klinefelter’s

Clarifying the blurry boundaries between research and clinical care

The importance of defining actionability as related to disclosure of secondary findings identified in research

When to disclose a borderline incidental finding

To disclose or not to disclose: Secondary findings of XXY chromosomes

Interview Guide: Genetic Health Professionals’ Experiences with Informed Consent in Diagnostic Genomic Sequencing

Select ethical aspects of next-generation sequencing tests for newborn screening and diagnostic evaluation of critically ill newborns

Development and validation of a comprehensive genomics knowledge scale

Sequence three million genomes across Africa